UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

Asenapine pharmacokinetics and tolerability in a pediatric population

Drug design, development and therapy, 2018, Vol.12, p.2677-2693

2018

Volltextzugriff (PDF)

Phase 1 Study To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Oral Doses of DS-2969b, a Novel GyrB Inhibitor, in Healthy Subjects

Antimicrobial agents and chemotherapy, 2018-05, Vol.62 (5)

2018

Volltextzugriff (PDF)

A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of DS‐3801b, a Motilin Receptor Agonist, in Healthy Subjects

Journal of clinical pharmacology, 2017-09, Vol.57 (9), p.1221-1230

2017

Volltextzugriff (PDF)

Abstract CT098: KEYNOTE-046: Effects of ADXS-PSA with or without pembrolizumab on survival and antigen spreading in metastatic, castration-resistant prostate cancer patients

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.CT098-CT098

2019

Volltextzugriff (PDF)

A Phase I, Single‐Ascending‐Dose Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DS‐2969b, a Novel GyrB Inhibitor

Journal of clinical pharmacology, 2018-12, Vol.58 (12), p.1557-1565

2018

Volltextzugriff (PDF)

Abstract CT007: Safety and immunogenicity of a personalized neoantigen- Listeria vaccine in cancer patients

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.CT007-CT007

2019

Volltextzugriff (PDF)

Quantification, Variability, and Reproducibility of Basal Skeletal Muscle Glucose Uptake in Healthy Humans Using 18 F-FDG PET/CT

Journal of Nuclear Medicine, 2015-10, Vol.56 (10), p.1520-1526

2015

Volltextzugriff (PDF)

Quantification, Variability, and Reproducibility of Basal Skeletal Muscle Glucose Uptake in Healthy Humans Using ^sup 18^F-FDG PET/CT

The Journal of nuclear medicine (1978), 2015-10, Vol.56 (10), p.1520

2015

Volltextzugriff (PDF)

Quantification, Variability, and Reproducibility of Basal Skeletal Muscle Glucose Uptake in Healthy Humans Using sigma up 18 Theta -FDG PET/CT

The Journal of nuclear medicine (1978), 2015-10, Vol.56 (10), p.1520-1520

2015

Volltextzugriff (PDF)

A Phase 1 Study in Healthy Subjects to Investigate Safety, Pharmacokinetics, and Effect on Intestinal Flora of Multiple Ascending Doses of DS-2969b, A Novel Oral DNA Gyrase B Inhibitor for The Treatment of Clostridium difficile Infection

Open forum infectious diseases, 2017-10, Vol.4 (suppl_1), p.S526-S526

2017

Volltextzugriff (PDF)

Lack of a clinically relevant effect of sugammadex on anti-Xa activity or activated partial thromboplastin time following pretreatment with either unfractionated or low-molecular-weight heparin in healthy subjects

International journal of clinical pharmacology and therapeutics, 2014-08, Vol.52 (8), p.631

2014

Volltextzugriff (PDF)

An LC-MRM method for measuring intestinal triglyceride assembly using an oral stable isotope-labeled fat challenge

Bioanalysis, 2016-06, Vol.8 (12), p.1265-1277

2016

Volltextzugriff (PDF)

Effect of Sugammadex on QT/QTc Interval Prolongation when Combined with QTc-Prolonging Sevoflurane or Propofol Anaesthesia

Clinical drug investigation, 2013-08, Vol.33 (8), p.545-551

2013

Volltextzugriff (PDF)

Quantification, Variability, and Reproducibility of Basal Skeletal Muscle Glucose Uptake in Healthy Humans Using 18F-FDG PET/CT

The Journal of nuclear medicine (1978), 2015-10, Vol.56 (10), p.1520-1526

2015

Volltextzugriff (PDF)

Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy

Nature communications, 2016-01, Vol.7 (1), p.10582-10582, Article 10582

2016

Volltextzugriff (PDF)

Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade

Cancer immunology research, 2016-11, Vol.4 (11), p.959-967

2016

Volltextzugriff (PDF)

MAESTRO-Pool Enables Highly Parallel and Specific Mutation-Enrichment Sequencing for Minimal Residual Disease Detection in Cohort Studies

Clinical chemistry (Baltimore, Md.), 2024-02, Vol.70 (2), p.434-443

2024

Volltextzugriff (PDF)

Development of a Scalable Synthesis of a Drug-Linker for ABBV-3373

Organic process research & development, 2024-06, Vol.28 (6), p.2237-2246

2024

Volltextzugriff (PDF)

A phase II study of temsirolimus and erlotinib in patients with recurrent and/or metastatic, platinum-refractory head and neck squamous cell carcinoma

Oral oncology, 2013-05, Vol.49 (5), p.461-467

2013

Volltextzugriff (PDF)

Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate During Pregnancy

Clinical infectious diseases, 2015-09, Vol.61 (6), p.996-1003

2015

Volltextzugriff (PDF)

Use of Impinging Jet to Improve Scalability in the Preparation of the ABBV-154 Drug-Linker

Organic process research & development, 2024-07, Vol.28 (7), p.2518-2533

2024

Volltextzugriff (PDF)

Development and Execution of a Scalable Route to an Immunology ADC Drug-Linker for ABBV-154

Organic process research & development, 2024-07, Vol.28 (7), p.2499-2517

2024

Volltextzugriff (PDF)

Stochastic preemptive goal programming of Air Force weapon systems mix

Journal of defense modeling and simulation, 2023-04, Vol.20 (2), p.147-158

2023

Volltextzugriff (PDF)

Hybrid capture-based next-generation sequencing (HC NGS) in melanoma to identify markers of response to anti-PD-1/PD-L1

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.105-105

2016

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(29)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Asenapine pharmacokinetics and tolerability in a pediatric population

Phase 1 Study To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Oral Doses of DS-2969b, a Novel GyrB Inhibitor, in Healthy Subjects

A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of DS‐3801b, a Motilin Receptor Agonist, in Healthy Subjects

Abstract CT098: KEYNOTE-046: Effects of ADXS-PSA with or without pembrolizumab on survival and antigen spreading in metastatic, castration-resistant prostate cancer patients

A Phase I, Single‐Ascending‐Dose Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DS‐2969b, a Novel GyrB Inhibitor

Abstract CT007: Safety and immunogenicity of a personalized neoantigen- Listeria vaccine in cancer patients

Quantification, Variability, and Reproducibility of Basal Skeletal Muscle Glucose Uptake in Healthy Humans Using 18 F-FDG PET/CT

Quantification, Variability, and Reproducibility of Basal Skeletal Muscle Glucose Uptake in Healthy Humans Using ^sup 18^F-FDG PET/CT

Quantification, Variability, and Reproducibility of Basal Skeletal Muscle Glucose Uptake in Healthy Humans Using sigma up 18 Theta -FDG PET/CT

A Phase 1 Study in Healthy Subjects to Investigate Safety, Pharmacokinetics, and Effect on Intestinal Flora of Multiple Ascending Doses of DS-2969b, A Novel Oral DNA Gyrase B Inhibitor for The Treatment of Clostridium difficile Infection

Lack of a clinically relevant effect of sugammadex on anti-Xa activity or activated partial thromboplastin time following pretreatment with either unfractionated or low-molecular-weight heparin in healthy subjects

An LC-MRM method for measuring intestinal triglyceride assembly using an oral stable isotope-labeled fat challenge

Effect of Sugammadex on QT/QTc Interval Prolongation when Combined with QTc-Prolonging Sevoflurane or Propofol Anaesthesia

Quantification, Variability, and Reproducibility of Basal Skeletal Muscle Glucose Uptake in Healthy Humans Using 18F-FDG PET/CT

Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy

Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade

MAESTRO-Pool Enables Highly Parallel and Specific Mutation-Enrichment Sequencing for Minimal Residual Disease Detection in Cohort Studies

Development of a Scalable Synthesis of a Drug-Linker for ABBV-3373

A phase II study of temsirolimus and erlotinib in patients with recurrent and/or metastatic, platinum-refractory head and neck squamous cell carcinoma

Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate During Pregnancy

Use of Impinging Jet to Improve Scalability in the Preparation of the ABBV-154 Drug-Linker

Development and Execution of a Scalable Route to an Immunology ADC Drug-Linker for ABBV-154

OUTSMART HF: A Randomized Controlled Trial of Routine Versus Selective Cardiac Magnetic Resonance for Patients With Nonischemic Heart Failure (IMAGE-HF 1B)

Stochastic preemptive goal programming of Air Force weapon systems mix

Hybrid capture-based next-generation sequencing (HC NGS) in melanoma to identify markers of response to anti-PD-1/PD-L1

Suchergebnisse filtern